These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10775292)

  • 1. Hypercalcaemia in a 63 year old man.
    Ranganath L; Semple MJ
    Postgrad Med J; 2000 May; 76(895):309-10, 313-4. PubMed ID: 10775292
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
    Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG
    Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of diphosphonates in myeloma.
    Kanis JA; Paterson AD; Russell RG
    Br J Haematol; 1983 Apr; 53(4):688-90. PubMed ID: 6219695
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypercalcemic crises of myelomatous origin. Treatment with dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I
    Presse Med; 1984 Nov; 13(42):2586. PubMed ID: 6239268
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of diphosphonates in hypercalcaemia due to malignancy.
    Kanis JA; McCloskey EV; Paterson AH
    Lancet; 1990 Jan; 335(8682):170-1. PubMed ID: 1967461
    [No Abstract]   [Full Text] [Related]  

  • 6. Immobilisation hypercalcaemia in adults and treatment with clodronate.
    Yates AJ; Jones TH; Mundy KI; Hague RV; Brown CB; Guilland-Cumming D; Kanis JA
    Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1111-2. PubMed ID: 6237713
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diphosphonates in the treatment of hypercalcemia].
    Delmas PD; Meunier PJ
    Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.
    Jüngst D
    Lancet; 1984 Nov; 2(8410):1043. PubMed ID: 6149425
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of bisphosphonates in hypercalcaemia due to malignancy.
    Ralston SH; Gallacher SJ; Patel U; Fraser WD; Dryburgh FJ; Boyle IT
    Lancet; 1990 Mar; 335(8691):737. PubMed ID: 1969100
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of clodronate on bone density in patients with multiple myeloma--a 2-year follow-up of therapeutic effects].
    Adam Z; Prokes B; Znojĭl V; Vorlícek J; Hejlová N; Hájek D; Krejcí M
    Vnitr Lek; 1996 Jun; 42(6):379-85. PubMed ID: 8928406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypercalcemia of myelomatous origin with intravenous diphosphonates].
    Charhon S; Chapuy MC; Valentin-Opran A; Edouard C; Rosini S; Meunier PJ
    Presse Med; 1983 Dec; 12(47):2983-6. PubMed ID: 6228888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia and hypercalcemia: treatment with dichloromethylene diphosphonate.
    Siris ES; Grossbard L; Halper JP; Blume RS; Jacobs TP
    Metab Bone Dis Relat Res; 1983-1984; 5(2):61-3. PubMed ID: 6231452
    [No Abstract]   [Full Text] [Related]  

  • 13. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of painful bone lesions and hypercalcemia.
    Ascari E; Attardo-Parrinello G; Merlini G
    Eur J Haematol Suppl; 1989; 51():135-9. PubMed ID: 2534078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of diphosphonates in the treatment of hypercalcemia in multiple myeloma: efficacy of 4-amino-hydroxybutylidene-1,1-bisphosphonate (AHButBP)].
    Attardo-Parrinello G; Crema F; Merlini G; Spaghi A; Fiorentini ML
    Medicina (Firenze); 1988; 8(1):75-6. PubMed ID: 3226251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of intravenous dichloromethylene diphosphonate in paraneoplastic hypercalcemia resistant to mithramycin].
    Peyron R; Sereni D; Grateau G; Boissonnas A; Cremer GA; Laroche C
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):435-7. PubMed ID: 6238399
    [No Abstract]   [Full Text] [Related]  

  • 18. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis].
    Abe M
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.